Tirofiban structure
|
Common Name | Tirofiban | ||
---|---|---|---|---|
CAS Number | 144494-65-5 | Molecular Weight | 440.597 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | 611.7±65.0 °C at 760 mmHg | |
Molecular Formula | C22H36N2O5S | Melting Point | 223-225ºC | |
MSDS | N/A | Flash Point | 323.7±34.3 °C |
Use of TirofibanTirofiban(L700462;MK383) is a potent non-peptide, glycoprotein IIb/IIIa (integrins alphaIIbbetaIII) antagonistTarget: integrin IIb/IIIa Tirofiban hydrochloride monohydrate blocks platelet aggregation and thrombus formation. Tirofiban is an antithrombotic used in the treatment of unstable angina.Tirofiban, in a concentration-dependent manner reduced platelet aggregation evoked by ADP (IC50 approximately 70 ng/ml), collagen (IC50 approximately 200 ng/ml), and thrombin (IC50 approximately 5,000 ng/ml). |
Name | tirofiban |
---|---|
Synonym | More Synonyms |
Description | Tirofiban(L700462;MK383) is a potent non-peptide, glycoprotein IIb/IIIa (integrins alphaIIbbetaIII) antagonistTarget: integrin IIb/IIIa Tirofiban hydrochloride monohydrate blocks platelet aggregation and thrombus formation. Tirofiban is an antithrombotic used in the treatment of unstable angina.Tirofiban, in a concentration-dependent manner reduced platelet aggregation evoked by ADP (IC50 approximately 70 ng/ml), collagen (IC50 approximately 200 ng/ml), and thrombin (IC50 approximately 5,000 ng/ml). |
---|---|
Related Catalog | |
References |
[4]. Valgimigli M, Tebaldi M. Safety evaluation of tirofiban. Expert Opin Drug Saf. 2010 Sep;9(5):801-19. |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 611.7±65.0 °C at 760 mmHg |
Melting Point | 223-225ºC |
Molecular Formula | C22H36N2O5S |
Molecular Weight | 440.597 |
Flash Point | 323.7±34.3 °C |
Exact Mass | 440.234497 |
PSA | 113.11000 |
LogP | 4.14 |
Vapour Pressure | 0.0±1.8 mmHg at 25°C |
Index of Refraction | 1.532 |
Storage condition | -20°C |
Hazard Codes | Xi |
---|---|
Risk Phrases | 36/37/38 |
Safety Phrases | S22-S26-S30-S36/37/39-S45 |
RIDADR | UN3261 |
Packaging Group | II |
Hazard Class | 8 |
HS Code | 2942000000 |
~99% Tirofiban CAS#:144494-65-5 |
Literature: Chung; Zhao; Hughes; Grabowski Tetrahedron, 1993 , vol. 49, # 26 p. 5767 - 5776 |
~% Tirofiban CAS#:144494-65-5 |
Literature: Tetrahedron, , vol. 49, # 26 p. 5767 - 5776 |
Precursor 2 | |
---|---|
DownStream 0 |
HS Code | 2942000000 |
---|
Tirofiban [BAN:INN] |
N-(Butylsulfonyl)-O-[4-(piperidin-4-yl)butyl]-L-tyrosine |
N-(n-butanesulfonyl)-O-(4-(4-piperidinyl)butyl)-(S)-tyrosine |
MFCD05237246 |
2-S-(n-Butylsulfonylamino)-3[4-(piperidin-4-yl)butyloxyphenyl]propionic acid |
(S)-2-(butane-1-sulfonylamino)-3-[4-(4-piperidin-4-yl-butoxy)phenyl]-propionic acid |
Agrastat |
Agrastat (TN) |
N-(Butylsulfonyl)-O-[4-(4-piperidinyl)butyl]tyrosine |
(2S)-2-(butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid |
UNII-GGX234SI5H |
Aggrastat |
Tirofiban |
Tirofiban (INN) |
Tyrosine, N-(butylsulfonyl)-O-[4-(4-piperidinyl)butyl]- |
(2S)-2-(butane-1-sulfonamido)-3-{4-[4-(piperidin-4-yl)butoxy]phenyl}propanoic acid |
N-(BUTYLSULFONYL)-O-[4-(4-PIPERIDINYL)BUTYL]-L-TYROSINE |
L-tyrosine, N-(butylsulfonyl)-O-[4-(4-piperidinyl)butyl]- |
L700462 |
MK383 |